Review
Tuberculosis and multi-drug resistant tuberculosis in children
- PMID: 8700614
Item in Clipboard
Review
Tuberculosis and multi-drug resistant tuberculosis in children
Pediatr Nurs.
1995 Nov-Dec.
Abstract
Infection and disease caused by Mycobacterium tuberculosis remain a hugh global problem, and are not well controlled in several areas within the United States. Co-infection with the human immunodeficiency virus (HIV) and immigration from areas with high rates of tuberculosis contribute to the problem in the United States. Organisms resistant to the two main drugs, isoniazid and rifampin, known as multidrug-resistant M. tuberculosis or MDR-TB, present serious therapeutic challenges. Strategies for the management of such cases are presented.
Similar articles
-
Mini epidemic of isoniazide resistant TB in rural TN: a need for supervised preventive therapy.Tenn Med. 2009 Aug;102(8):41-4. Tenn Med. 2009. PMID: 19691201
-
Risk factors and outcome of human immunodeficiency virus-infected patients with sporadic multidrug-resistant tuberculosis in New York City.Int J Tuberc Lung Dis. 1997 Aug;1(4):319-25. Int J Tuberc Lung Dis. 1997. PMID: 9432387
-
Failure of chemoprophylaxis with standard antituberculosis agents in child contacts of multidrug-resistant tuberculosis cases.Pediatr Infect Dis J. 2007 Dec;26(12):1142-6. doi: 10.1097/INF.0b013e31814523e4. Pediatr Infect Dis J. 2007. PMID: 18043453
-
[Development of antituberculous drugs: current status and future prospects].Kekkaku. 2006 Dec;81(12):753-74. Kekkaku. 2006. PMID: 17240921 Review. Japanese.
-
Drug-resistant tuberculosis: controversies and challenges in pediatrics.Expert Rev Anti Infect Ther. 2005 Dec;3(6):995-1010. doi: 10.1586/14787210.3.6.995. Expert Rev Anti Infect Ther. 2005. PMID: 16307511 Review.
Cited by
-
Rifampin-resistant Tuberculosis in the United States, 1998-2014.Clin Infect Dis. 2020 Apr 10;70(8):1596-1605. doi: 10.1093/cid/ciz491. Clin Infect Dis. 2020. PMID: 31233131 Free PMC article.